| Year |
Citation |
Score |
| 2022 |
Bascou NA, Haslund-Gourley B, Amber-Monta K, Samson K, Goss N, Meredith D, Friedman A, Needleman A, Kumar VK, Fischer BD. Reducing the stigma surrounding opioid use disorder: evaluating an opioid overdose prevention training program applied to a diverse population. Harm Reduction Journal. 19: 5. PMID 35034649 DOI: 10.1186/s12954-022-00589-6 |
0.462 |
|
| 2021 |
Rahman MA, Keck TM, Poe MM, Sharmin D, Cook JM, Fischer BD. Synergistic antihyperalgesic and antinociceptive effects of morphine and methyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (MP-III-024): a positive allosteric modulator at α2GABA and α3GABA receptors. Psychopharmacology. PMID 33585961 DOI: 10.1007/s00213-021-05791-1 |
0.512 |
|
| 2020 |
Islam A, Rahman MA, Brenner MB, Moore A, Kellmyer A, Buechler HM, DiGiorgio F, Verchio VR, McCracken L, Sumi M, Hartley R, Lizza JR, Moura-Letts G, Fischer BD, Keck TM. Abuse Liability, Anti-Nociceptive, and Discriminative Stimulus Properties of IBNtxA. Acs Pharmacology & Translational Science. 3: 907-920. PMID 33073190 DOI: 10.1021/acsptsci.0c00066 |
0.704 |
|
| 2017 |
Kroll C, Fischer BD. Response rate decreasing effects of naloxone during chronic sucrose availability. Behavioural Pharmacology. PMID 28418942 DOI: 10.1097/FBP.0000000000000306 |
0.615 |
|
| 2017 |
Fischer BD, Schlitt RJ, Hamade BZ, Rehman S, Ernst M, Poe MM, Li G, Kodali R, Arnold LA, Cook JM. Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABAA receptor ligand MP-III-024. Brain Research Bulletin. PMID 28267561 DOI: 10.1016/J.Brainresbull.2017.03.001 |
0.393 |
|
| 2017 |
Fischer BD. GABA-A receptor subtypes: Implications for the treatment of pain. Cns & Neurological Disorders Drug Targets. PMID 28176641 DOI: 10.2174/1871527316666170207155149 |
0.448 |
|
| 2017 |
Kroll C, Fischer BD. Naloxone-precipitated withdrawal following sucrose self-administration in C57bl/6 mice Drug and Alcohol Dependence. 171: e111. DOI: 10.1016/j.drugalcdep.2016.08.311 |
0.32 |
|
| 2015 |
Fischer BD, Platt DM, Rallapalli SK, Namjoshi OA, Cook JM, Rowlett JK. Antagonism of triazolam self-administration in rhesus monkeys responding under a progressive-ratio schedule: In vivo apparent pA2 analysis. Drug and Alcohol Dependence. PMID 26596587 DOI: 10.1016/J.Drugalcdep.2015.10.026 |
0.332 |
|
| 2014 |
Sawyer EK, Fischer B, Meng Z, Poe M, Namjoshi O, Cook J, Rowlett J. Role of α3GABAA receptor modulation in the anti-conflict effects of benzodiazepine-type drugs in monkeys Drug and Alcohol Dependence. 140: e196-e197. DOI: 10.1016/J.Drugalcdep.2014.02.548 |
0.307 |
|
| 2013 |
Fischer BD, Teixeira LP, van Linn ML, Namjoshi OA, Cook JM, Rowlett JK. Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation. Psychopharmacology. 227: 347-54. PMID 23354533 DOI: 10.1007/S00213-013-2975-2 |
0.553 |
|
| 2013 |
Shinday NM, Sawyer EK, Fischer BD, Platt DM, Licata SC, Atack JR, Dawson GR, Reynolds DS, Rowlett JK. Reinforcing effects of compounds lacking intrinsic efficacy at α1 subunit-containing GABAA receptor subtypes in midazolam- but not cocaine-experienced rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1006-14. PMID 23303046 DOI: 10.1038/Npp.2012.265 |
0.412 |
|
| 2011 |
Dykstra LA, Fischer BD, Balter RE, Henry FE, Schmidt KT, Miller LL. Opioid antinociception, tolerance and dependence: interactions with the N-methyl-D-aspartate system in mice. Behavioural Pharmacology. 22: 540-7. PMID 21712708 DOI: 10.1097/FBP.0b013e328348ed08 |
0.673 |
|
| 2011 |
Fischer BD. Preclinical assessment of drug combinations for the treatment of pain: isobolographic and dose-addition analysis of the opioidergic system. Cns & Neurological Disorders Drug Targets. 10: 529-35. PMID 21631411 |
0.588 |
|
| 2010 |
Fischer BD, Ward SJ, Henry FE, Dykstra LA. Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects. Neuropharmacology. 58: 544-50. PMID 19699755 DOI: 10.1016/j.neuropharm.2009.08.005 |
0.762 |
|
| 2008 |
Fischer BD, Miller LL, Henry FE, Picker MJ, Dykstra LA. Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959). Psychopharmacology. 198: 271-8. PMID 18392754 DOI: 10.1007/s00213-008-1130-y |
0.686 |
|
| 2008 |
Fischer BD, Zimmerman EI, Picker MJ, Dykstra LA. Morphine in combination with metabotropic glutamate receptor antagonists on schedule-controlled responding and thermal nociception. The Journal of Pharmacology and Experimental Therapeutics. 324: 732-9. PMID 17982001 DOI: 10.1124/jpet.107.131417 |
0.804 |
|
| 2006 |
Fischer BD, Dykstra LA. Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception. The Journal of Pharmacology and Experimental Therapeutics. 318: 1300-6. PMID 16772537 DOI: 10.1124/jpet.106.101683 |
0.796 |
|
| 2005 |
Fischer BD, Carrigan KA, Dykstra LA. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice. The Journal of Pain : Official Journal of the American Pain Society. 6: 425-33. PMID 15993820 DOI: 10.1016/J.Jpain.2005.02.003 |
0.815 |
|
| 2002 |
Bowen CA, Fischer BD, Mello NK, Negus SS. Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 302: 264-73. PMID 12065726 DOI: 10.1124/Jpet.302.1.264 |
0.698 |
|
| 2001 |
Brandt MR, Furness MS, Rice KC, Fischer BD, Negus SS. Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation. The Journal of Pharmacology and Experimental Therapeutics. 299: 629-37. PMID 11602675 |
0.582 |
|
| 2001 |
Negus SS, Pope HG, Kanayama G, Wines JD, Fischer BD. Lack of evidence for opioid tolerance or dependence in rhesus monkeys following high-dose anabolic-androgenic steroid administration. Psychoneuroendocrinology. 26: 789-96. PMID 11585679 DOI: 10.1016/S0306-4530(01)00028-2 |
0.663 |
|
| Show low-probability matches. |